- Home
- JBI vs NVCR Comparison
JBI vs NVCR Comparison
Compare JBI & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBI
- NVCR
- Stock Information
- Founded
- JBI 2002
- NVCR 2000
- Country
- JBI United States
- NVCR Switzerland
- Employees
- JBI N/A
- NVCR N/A
- Industry
- JBI Building Products
- NVCR Medical/Dental Instruments
- Sector
- JBI Industrials
- NVCR Health Care
- Exchange
- JBI Nasdaq
- NVCR Nasdaq
- Market Cap
- JBI 1.2B
- NVCR 1.4B
- IPO Year
- JBI N/A
- NVCR 2015
- Fundamental
- Price
- JBI $10.07
- NVCR $14.38
- Analyst Decision
- JBI Buy
- NVCR Buy
- Analyst Count
- JBI 4
- NVCR 7
- Target Price
- JBI $10.50
- NVCR $28.79
- AVG Volume (30 Days)
- JBI 671.3K
- NVCR 1.8M
- Earning Date
- JBI 11-06-2025
- NVCR 10-30-2025
- Dividend Yield
- JBI N/A
- NVCR N/A
- EPS Growth
- JBI N/A
- NVCR N/A
- EPS
- JBI 0.30
- NVCR N/A
- Revenue
- JBI $899,500,000.00
- NVCR $630,160,000.00
- Revenue This Year
- JBI N/A
- NVCR $6.68
- Revenue Next Year
- JBI $3.56
- NVCR $7.01
- P/E Ratio
- JBI $32.32
- NVCR N/A
- Revenue Growth
- JBI N/A
- NVCR 14.58
- 52 Week Low
- JBI $5.99
- NVCR $10.87
- 52 Week High
- JBI $10.80
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- JBI 53.97
- NVCR 59.00
- Support Level
- JBI $9.79
- NVCR $13.57
- Resistance Level
- JBI $10.20
- NVCR $14.60
- Average True Range (ATR)
- JBI 0.28
- NVCR 0.69
- MACD
- JBI 0.02
- NVCR 0.01
- Stochastic Oscillator
- JBI 82.78
- NVCR 79.90
About JBI Janus International Group Inc.
Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.